Tracked shipping to South Africa with premium packaging for just R199 

Ship to
South Africa
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Chromatin Deregulation in Cancer
Type
Physical Book
Publisher
Author
Language
English
Pages
382
Format
Hardcover
Dimensions
25.9 x 18.3 x 2.3 cm
Weight
1.09 kg.
ISBN13
9781621821403
Categories

Chromatin Deregulation in Cancer

Armstrong, Scott A. ; Henikoff, Steven ; Vakoc, Christopher R. (Author) · Cold Spring Harbor Laboratory Press · Hardcover

Chromatin Deregulation in Cancer - Armstrong, Scott A. ; Henikoff, Steven ; Vakoc, Christopher R.

New Book Imported to South Africa
Delivery: 17 Jul - 14 Aug Shipping: 12 to 16 business days.
R 648
R 648

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Chromatin Deregulation in Cancer"

The human genome is packaged into chromatin, which is composed of numerous proteins that help control gene expression, DNA replication and repair, and genome stability. In recent years, it has become clear that the deregulation of chromatin structure plays an important role in numerous cancers. Written and edited by experts in the field, this collection from Cold Spring Harbor Perspectives in Medicine examines the chromatin components that are commonly mutated, what is understood about the mechanisms that lead to hematological malignancies and solid tumors, and prospects for the therapeutic modulation of chromatin. The contributors describe how histone proteins, histone-modifying enzymes, chromatin remodelers, transcriptional regulatory complexes, enhancer-associated factors, and signaling proteins are dysregulated in cancer pathogenesis. In addition, the roles of DNA methylation and noncoding RNAs are covered. The authors also discuss small molecules and other drugs that are currently under development or already used to treat cancer (e.g., HDAC inhibitors and DNA hypomethylating agents). This book is therefore essential reading for all cancer biologists, cell and molecular biologists, and pharmacologists interested in understanding cancer therapies.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews